Related Experiment Video

Updated: Aug 17, 2026

Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity
10:22

Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity

Published on: September 16, 2011

33.5K

Correction to: Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to

Yujie Liu1, Jianhua Xie1, Zhuxiang Li1

  • 1Bio-Thera Solutions, Ltd, Floor 5, Building A6, 11 Kai-Yuan Blvd, Huangpu District, Guangzhou, 510530, Guangdong, China.

Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|August 21, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.7K
Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

550

Related Experiment Videos

Last Updated: Aug 17, 2026

Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity
10:22

Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity

Published on: September 16, 2011

33.5K
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.7K
Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

550

Related Concept Videos

Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...

Articles linked to this work by shared authors, journal, and citation graph.

Correction: Gut microbial biomarkers for major depressive disorder: a cross-sectional study.

Frontiers in cellular and infection microbiology·2026

Efficacy and safety of transurethral thulium laser cauterization in male patients with urethral hemangioma: a single-center retrospective case series.

Translational andrology and urology·2026

Association Between the Triglyceride-Glucose Index and Clinical Outcomes Modified by Diabetes Duration in Patients with Acute Coronary Syndrome and Type 2 Diabetes Mellitus.

Diabetes, metabolic syndrome and obesity : targets and therapy·2026

Sucrose and starch metabolism pathways as candidate regulatory pathways in the salt stress response revealed by transcriptomic and metabolomic analysis during soybean (Glycine max) germination.

Functional & integrative genomics·2026

Gut microbial biomarkers for major depressive disorder: a cross-sectional study.

Frontiers in cellular and infection microbiology·2026

Neuroprotective effects of AnMei decoction on hypothalamic neuronal injury and circadian rhythm dysregulation in murine models of insomnia.

Journal of ethnopharmacology·2026

From Reflection to Implementation: Tailored Clinical Development of a Pembrolizumab Biosimilar Candidate.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026

HLX11: A Pertuzumab Biosimilar.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026

Plant-Based Systems for Producing Therapeutic Proteins: Current Status and Future Prospects.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026

Beyond the Prevention of Anti-drug Antibody Formation with Uricase Therapy: Mechanistic Roles of DMARDs in Modifying Gout Flare Risk.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026

Biologic Therapies for Alleviating Neurodegeneration in Lysosomal Storage Diseases.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026

Biosimilars: A Virtuous Cycle of Sustainability and Innovation.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026

Symptoms improvement and lung function benefits of fixed triple therapy with beclomethasone/formoterol/glycopyrronium inhalation powder in patients with moderate-to-severe COPD: outcomes of the Bulgarian arm of the RESPONSE study.

Journal of thoracic disease·2026

From maturation to degeneration: Distinct biological trajectories in bicuspid and tricuspid aortopathy.

Experimental physiology·2026

Real-time three-dimensional echocardiographic assessment of the association between aortic diameter and left ventricular mechanical dyssynchrony in patients with bicuspid aortic valve.

Quantitative imaging in medicine and surgery·2026

Mid-term clinical outcomes of one and two patient-specific mini-implants for focal (osteo-)chondral lesions of the distal femur.

Journal of ISAKOS : joint disorders & orthopaedic sports medicine·2026

Body mass index and robotic-assisted total hip arthroplasty: current evidence, technical challenges, and clinical implications-a critical review.

Journal of robotic surgery·2026

Limb salvage for an aorto-bifemoral vascular graft infection using multilayer negative pressure wound therapy: a case report.

International journal of surgery case reports·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us